Arvind Sharma

Arvind Sharma (born 1 August 1981) is an Indian pharmaceutical entrepreneur, formulation specialist, and business executive. He is the Managing Director of Meyonex Pharmaceuticals Ltd., a WHO-GMP and PIC/S certified Contract Development and Manufacturing Organisation (CDMO) located at Tarapur MIDC, Boisar, Maharashtra. He is also the founder of TruRelief Biorganics Pvt. Ltd., an Ayurvedic healthcare company focused on clinically evaluated pain-relief formulations.

Originally trained as an electronics and instrumentation engineer, Sharma transitioned into the pharmaceutical industry during the mid-2000s. Since then, he has developed expertise in pharmaceutical manufacturing, formulation research, regulatory compliance, technology transfer, and export-oriented product development across international markets.

Early Life and Education

Arvind Sharma was born on 1 August 1981 in Gorakhpur, Uttar Pradesh, India.

He completed his Bachelor of Engineering (B.E.) in Electronics from A. C. Patil College of Engineering, Kharghar, Navi Mumbai, affiliated with the University of Mumbai, in 2003.

To strengthen his business and marketing knowledge, he later earned an Advanced Post Graduate Diploma in Management Studies (Marketing) from The ICFAI University, Tripura, in 2009.

Career

Sharma began his professional career in 2003 as a Project and Development Engineer with Capital Controls (India) Private Limited in Mumbai. During this period, he managed turnkey water treatment and chlorination projects, gaining experience in industrial automation, engineering design, and project execution.

In 2006, he joined Pam-Glatt Pharma Technologies Private Limited as an Electronics and Instrumentation Engineer. His responsibilities included PLC programming, SCADA systems, control panel design, and commissioning of pharmaceutical manufacturing equipment. He also contributed to the development of the Human-Machine Interface (HMI) for an automated pharmaceutical coating system developed in collaboration with Pam Germany.

This experience marked his transition from engineering into pharmaceutical manufacturing and laid the foundation for his future work in pharmaceutical process development and formulation science.

Between 2008 and 2012, Sharma served as the Chief Executive Officer of Quality Nexgen Pharmaceuticals Pvt. Ltd. During his tenure, he supervised the manufacturing and export of pharmaceutical formulations, including tablets, capsules, liquid oral preparations, and external dosage forms.

From 2013 to 2015, he worked independently as a pharmaceutical formulation consultant, assisting pharmaceutical companies in developing products for various Rest-of-World (ROW) markets.

Meyonex Pharmaceuticals

Since January 2015, Arvind Sharma has served as the Managing Director of Meyonex Pharmaceuticals Ltd.

Under his leadership, the company has established itself as a WHO-GMP and PIC/S certified Contract Development and Manufacturing Organisation (CDMO), providing end-to-end pharmaceutical development services from formulation research and manufacturing to regulatory documentation and commercial production.

The manufacturing facility is located at Tarapur MIDC, Boisar, Maharashtra, and supplies pharmaceutical products to thirteen export markets across Africa, Asia, Europe, and the Middle East.

At Meyonex Pharmaceuticals, Sharma oversees:

• Pharmaceutical formulation development
• Manufacturing Formula Record (MFR) preparation
• Process validation
• Regulatory documentation
• Technology transfer
• Commercial manufacturing
• Quality assurance
• Export registration support
• International regulatory compliance

Technical Work

Arvind Sharma has extensive experience in pharmaceutical formulation development across multiple dosage forms.

His technical expertise includes:

• Immediate-release tablets
• Film-coated tablets
• Modified-release tablets
• Hard gelatin capsules
• Topical gels
• Ointments
• Medicated oils
• Aerosol formulations
• Semi-solid dosage forms
• Self-Nanoemulsifying Drug Delivery Systems (SNEDDS)

His work includes pharmaceutical pre-formulation studies, excipient compatibility assessment, dissolution enhancement, bioavailability improvement, stability studies, process optimization, scale-up, and commercial technology transfer.

In addition to conventional pharmaceutical formulations, Sharma has specialized in Ayurvedic and phytopharmaceutical product development by integrating modern pharmaceutical development techniques with traditional herbal medicine systems.

Regulatory and Export Markets

Arvind Sharma has extensive experience in pharmaceutical regulatory affairs for Rest-of-World (ROW) markets, covering countries across Africa, the Middle East, South East Asia, the Commonwealth of Independent States (CIS), and Europe.

Under his leadership, Meyonex Pharmaceuticals Ltd. exports pharmaceutical products to 13 international markets, each with distinct regulatory requirements, product registration procedures, labelling standards, and inspection protocols.

His regulatory expertise is built upon WHO-GMP and PIC/S quality systems together with compliance under the Central Drugs Standard Control Organisation (CDSCO) of India. His responsibilities include manufacturing licence management, export authorisations, WHO-type certifications, product registrations, and regulatory documentation.

He has supervised the preparation of Common Technical Document (CTD) and ASEAN Common Technical Document (ACTD) dossiers, stability studies under Zone IVb climatic conditions, and country-specific product documentation, enabling successful registrations across multiple international jurisdictions.

TruRelief Biorganics

Arvind Sharma is the founder of TruRelief Biorganics Pvt. Ltd., an Ayurvedic healthcare company focused on evidence-based pain management solutions.

The company has developed a comprehensive five-product arthritis and joint pain management range comprising:

• Pain Relief Gel
• Knee Relief Oil
• Pain Relief Aerosol Spray
• Joint Care Capsules
• Joint Care Tablets

TruRelief Biorganics distinguishes itself through its emphasis on clinical validation. Its formulations have undergone randomized controlled clinical evaluations, including comparative studies against conventional topical pain-relief products. These studies demonstrated comparable pain relief while reporting higher patient satisfaction and no significant adverse effects.

The company's formulations combine standardized botanical extracts with advanced pharmaceutical delivery technologies, including menthol-camphor-capric acid deep eutectic penetration systems and cyclodextrin-based solubilization technology designed to enhance dermal drug delivery.

Professional Approach

Arvind Sharma is recognized for applying modern pharmaceutical research standards to both conventional and Ayurvedic medicines. His engineering background in electronics, instrumentation, and process automation has influenced a scientific and evidence-driven approach to pharmaceutical formulation.

His product development philosophy emphasizes laboratory validation, formulation stability, penetration studies, quality assurance, and clinical evaluation rather than marketing-driven product claims.

In addition to pharmaceutical research and manufacturing, Sharma actively explores emerging technologies including web development and artificial intelligence. He utilizes AI-assisted platforms for technical documentation, regulatory dossier preparation, knowledge management, and pharmaceutical business process optimization.

References

• Meyonex Pharmaceuticals Ltd. – Official Website: https://www.meyonex.com
• Official LinkedIn Profile of Arvind Sharma: https://www.linkedin.com/in/arvind-sharma-84a997219
• Product and Regulatory Documentation
• Clinical Trial Publications
• Trade Publications and Industry Coverage

External Links

• Website: https://www.meyonex.com
• LinkedIn: https://www.linkedin.com/in/arvind-sharma-84a997219